Nisar, Muhammad Imran
das, Sayan
Khanam, Rasheda
Khalid, Javairia
Chetia, Swagata
Hasan, Tarik
Shahid, Shahira
Marijani, Msafiri Ladislaus
Ahmed, Salahuddin
Khalid, Farah
Ali, Said Mohammed
Chowdhury, Nabidul Haque
Mehmood, Usma
Dutta, Arup
Rahman, Sayedur
Qazi, Muhammad Farrukh
Deb, Saikat
Mitra, Dipak Kumar
Usmani, Asra Abeer
Dhingra, Usha
Raqib, Rubhana
Manu, Alexander
Yoshida, Sachiyo
Minckas, Nicole
Bahl, Rajiv
Baqui, Abdullah H.
Sazawal, Sunil
Jehan, Fyezah
Funding for this research was provided by:
Bill and Melinda Gates Foundation (64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438, 64438)
Article History
Received: 15 August 2023
Accepted: 31 December 2023
First Online: 15 January 2024
Declarations
:
: The AMANHI study received ethical approval from the local and institutional ethics committees of all the three sites. These included Zanzibar Health Research Ethics Committee (formerly ZAMREC) (ZAMREC/0002/OCTOBER/013) for Tanzania, ICDDR, B (PR12073) and John Hopkins University (IRB 00004508) for Bangladesh and Aga Khan University (2790-paeds-ERC-13) for Pakistan. In addition, the protocols for the biorepository study were also approved by the WHO Ethics Review Committee (RPC 532) and continuing approvals were sought yearly. Written informed consent was obtained from study participants in which all study and sample handling and study procedures were explained in detail. HbA1c results were also shared with these participants.
: Not applicable.
: The authors declare no competing interests.